Breaking News Instant updates and real-time market news.

KITE

Kite Pharma

$51.80

1.24 (2.45%)

07:12
11/21/16
11/21
07:12
11/21/16
07:12

Kite Pharma initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Corey Davis started Kite Pharma with a Buy rating and $78 price target. While the competition for Chimeric Antigen Receptor T-cells is intense, Kite should have a big first-mover advantage with KTE-C19, Davis tells investors in a research note.

  • 03

    Dec

  • 03

    Dec

KITE Kite Pharma
$51.80

1.24 (2.45%)

09/27/16
LEER
09/27/16
NO CHANGE
LEER
Outperform
Kite's ZUMA-1 interim data incrementally positive for Juno, says Leerink
Leerink analyst Michael Schmidt says Kite Pharma's (KITE) top-line interim results from its pivotal ZUMA-1 trial of anti-CD19 CAR-T product KTE-C19 in patients with chemorefractory diffuse large B-cell lymphoma, or DLBCL, are incrementally positive for Juno Therapeutics (JUNO). While Juno is roughly one year behind Kite in DLBCL, the analyst believes its JCAR017 holds the promise to have a compelling safety/efficacy profile in lymphoma and Acute Lymphoblastic Leukemia. He reiterates an Outperform rating on Juno's shares.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
10/10/16
ADAM
10/10/16
NO CHANGE
Target $75
ADAM
Buy
Kite Pharma BLA filing still expected by year end, says Canaccord
Canaccord analyst John Newman noted Kite Pharma released 12 month update on Zuma-1 Phase 1, which showed durable efficacy and is encouraging despite coming from a small patient group. The analyst saw the release as a continuation of positive trends and expects a BLA filing by the end of 2016. Newman reiterated his Buy rating and $75 price target on Kite Pharma shares.
11/10/16
RBCM
11/10/16
NO CHANGE
RBCM
Kite Pharma weakness creates buying opportunity, says RBC Capital
After Kite's stock fell recently, RBC Capital analyst Michael Yee blames the pullback on macro worries about the biotech sector and a number of "short-term questions," about several issues, including upcoming ASH data, new durability data expected next quarter, and questions about the FDA's view of its drug. However, the analyst thinks that the company's comments indicate that its talks with the FDA are going well, and he says he remains upbeat on the company's pipeline. He expects "a lot" of concerns about the company to be mitigated in the next three to six m,months, as he thinks that it will report positive data in the near to medium term.The analyst keeps an $85 price target and an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

DDAIF

Daimler AG

$79.70

0.09 (0.11%)

09:31
09/25/17
09/25
09:31
09/25/17
09:31
Hot Stocks
Daimler Trucks tests truck platooning on public highways in the U.S. »

As the first commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPZ

Williams Partners

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Initiation
Williams Partners initiated  »

Williams Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Initiation
Williams initiated  »

Williams initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Recommendations
Yum! Brands analyst commentary  »

Yum! Brands' Taco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

ICPT

Intercept

$61.59

-12.11 (-16.43%)

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Hot Stocks
Intercept says talks with FDA 'evolving' »

When asked on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMMF

Summit Financial Group

$25.01

0.22 (0.89%)

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Downgrade
Summit Financial Group rating change  »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCMI

PCM, Inc.

$13.20

0.2 (1.54%)

09:29
09/25/17
09/25
09:29
09/25/17
09:29
Hot Stocks
PCM, Inc. acquires Stack Technology, subsidiaries »

PCM, Inc. has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

BIIB

Biogen

$318.46

3.43 (1.09%)

, NVO

Novo Nordisk

09:28
09/25/17
09/25
09:28
09/25/17
09:28
Hot Stocks
Biogen apponts Camille Lee as SVP, Alzheimer's Disease Therapeutic Area »

Biogen (BIIB) announced…

BIIB

Biogen

$318.46

3.43 (1.09%)

NVO

Novo Nordisk

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:27
09/25/17
09/25
09:27
09/25/17
09:27
Conference/Events
Wells Fargo financial team holds an analyst/industry conference call »

Wells Fargo Financial…

EXEL

Exelixis

$24.47

-3.54 (-12.64%)

, PTN

Palatin

09:24
09/25/17
09/25
09:24
09/25/17
09:24
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Exelixis (EXEL),…

EXEL

Exelixis

$24.47

-3.54 (-12.64%)

PTN

Palatin

AGN

Allergan

ICPT

Intercept

$61.59

-12.11 (-16.43%)

GPC

Genuine Parts

TGT

Target

LLY

Eli Lilly

AAPL

Apple

$151.89

-1.5 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

TSLA

Tesla

$351.09

-15.39 (-4.20%)

, GM

General Motors

09:24
09/25/17
09/25
09:24
09/25/17
09:24
Periodicals
China may ease foreign automaker rules aiding Tesla, WSJ reports »

China officials may ease…

TSLA

Tesla

$351.09

-15.39 (-4.20%)

GM

General Motors

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

F

Ford

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

  • 03

    Oct

  • 26

    Oct

SBRA

Sabra Health Care

$22.21

0.03 (0.14%)

09:23
09/25/17
09/25
09:23
09/25/17
09:23
Initiation
Sabra Health Care initiated  »

Sabra Health Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

09:20
09/25/17
09/25
09:20
09/25/17
09:20
General news
Treasury Action: supply is on tap this week »

Treasury Action: supply…

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/25/17
09/25
09:18
09/25/17
09:18
Options
Overnight activity included 98 trades in SPX and 33 trades in VIX »

98 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$24.50

1.04 (4.43%)

09:17
09/25/17
09/25
09:17
09/25/17
09:17
Recommendations
Nutanix analyst commentary  »

Nutanix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

09:16
09/25/17
09/25
09:16
09/25/17
09:16
Hot Stocks
Amazon signs first-look production deal with Casey Affleck's Sea Change Media »

Amazon Studios has closed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

09:15
09/25/17
09/25
09:15
09/25/17
09:15
General news
The Hurricane Lift for U.S. Producer Sentiment Has Begun: »

The Hurricane Lift for…

TUWOY

Tullow Oil

$1.19

0.08 (7.21%)

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Upgrade
Tullow Oil rating change  »

Tullow Oil upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$151.89

-1.5 (-0.98%)

, S

Sprint

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Recommendations
Apple, Sprint, STMicroelectronics analyst commentary  »

Initial Apple iPhone 8…

AAPL

Apple

$151.89

-1.5 (-0.98%)

S

Sprint

STM

STMicroelectronics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 22

    Oct

  • 16

    May

FINL

Finish Line

$9.73

0.51 (5.53%)

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Recommendations
Finish Line analyst commentary  »

Finish Line takeout…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.33

-0.12 (-0.19%)

09:13
09/25/17
09/25
09:13
09/25/17
09:13
Recommendations
Carnival analyst commentary  »

Carnival estimates raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

YUM

Yum! Brands

09:13
09/25/17
09/25
09:13
09/25/17
09:13
Conference/Events
Yum! Brands management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

09:12
09/25/17
09/25
09:12
09/25/17
09:12
Hot Stocks
Amazon signs multi-year deal with Amy Sherman-Palladino, Daniel Palladino »

Amazon announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

MSM

MSC Industrial

09:11
09/25/17
09/25
09:11
09/25/17
09:11
Initiation
MSC Industrial initiated  »

MSC Industrial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

LH

LabCorp

, DGX

Quest Diagnostics

09:10
09/25/17
09/25
09:10
09/25/17
09:10
Recommendations
LabCorp, Quest Diagnostics analyst commentary  »

LabCorp, Quest should be…

LH

LabCorp

DGX

Quest Diagnostics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.